Andreessen Horowitz launches 0M ‘bio fund’ to bridge gap between tech and biotech

Software venture giant Andreessen Horowitz just made a major pivot in its strategy: It’s folding biotechnology into its software-heavy portfolio, with a new $200 million fund to fuel startups that integrate biology and software. This is notable because the venture capital firm, when launched in 2009, was fairly adamant about keeping its investments within its area of expertise: Software. But the healthcare field’s draw is clearly too compelling to pass up. The firm’s core areas of interest are computational biomedicine and digital, beyond-the-pill approaches to therapy. “The firm has been excited about this space for a while, and we’ve made investments before even raising a bio fund,” writes Vijay Pande, a general partner at Andreessen Horowitz that will lead the fund, in a blog. “But we want to do something really big, and…


Link to Full Article: Andreessen Horowitz launches 0M ‘bio fund’ to bridge gap between tech and biotech